(Q39396223)

11 September 2017

Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block (English)

1 reference

11 September 2017

1 reference

1 reference

1 reference

1 reference

Biyun Cun

1

1 reference

11 September 2017

Xin Song

2

1 reference

11 September 2017

Renbing Jia

3

1 reference

11 September 2017

Xiaoping Zhao

4

1 reference

11 September 2017

Haibo Wang

5

1 reference

11 September 2017

Shengfang Ge

6

1 reference

11 September 2017

Xianqun Fan

7

1 reference

11 September 2017

language of work or name

1 reference

1 January 2012

1 reference

Cancer Biology and Therapy

11 September 2017

1 reference

11 September 2017

13

1 reference

11 September 2017

2

1 reference

11 September 2017

77-84

1 reference

Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

11 September 2017

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Ocular melanoma: relatively rare but requiring respect

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Metastatic melanoma: chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Clinical trials with oncolytic adenovirus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Intelligent design: combination therapy with oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Targeted therapy for uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Cancer cell death by design: apoptosis, autophagy and glioma virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Mechanisms of Immune Privilege in the Eye and Hair Follicle

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

Immune escape mechanisms of intraocular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.2.18436

21 January 2018

Identifiers

DOI

10.4161/CBT.13.2.18436

1 reference

11 September 2017

1 reference